World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
15598
World Ranking
3400
National Ranking
142

Adam K. Wheatley publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Adam K. Wheatley sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 222 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Adam K. Wheatley D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Adam K. Wheatley sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Adam K. Wheatley is affiliated with the University of Melbourne in Australia. Their research focuses extensively on immunology and infectious diseases, with significant contributions to understanding immune responses in viral infections, particularly SARS-CoV-2.

Their recent publications include research on immune protection and vaccine responses:

  • Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection, 2021, Nature Medicine
  • Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies, 2020, Nature Microbiology
  • Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19, 2020, Nature Medicine
  • Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19, 2021, Nature Communications
  • Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells, 2020, Science

Frequent coauthors collaborating with Wheatley include:

  • Stephen J. Kent
  • Jennifer A. Juno
  • Hyon-Xhi Tan
  • Katherine Kedzierska
  • Wen Shi Lee

Wheatley has published predominantly in these venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Immunology
  • Nature Communications
  • Immunology and Cell Biology
  • SSRN Electronic Journal

The main fields of study for Wheatley's work are Medicine and Immunology and Microbiology.

In terms of subfields, the research primarily covers:

  • Infectious Diseases
  • Immunology
  • Epidemiology
  • Molecular Biology
  • Radiology, Nuclear Medicine and Imaging

The main scientific topics addressed by Wheatley include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Influenza Virus Research Studies
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Respiratory viral infections research

Best Publications

  • Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.

    David S. Khoury;Deborah Cromer;Arnold Reynaldi;Timothy E. Schlub;Timothy E. Schlub

  • Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.

    Wen Shi Lee;Adam K Wheatley;Stephen J Kent;Stephen J Kent;Brandon J DeKosky

  • Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.

    Jennifer A. Juno;Hyon Xhi Tan;Wen Shi Lee;Arnold Reynaldi

  • Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.

    Marc Rigau;Marc Rigau;Simone Ostrouska;Thomas S Fulford;Darryl N Johnson

  • Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.

    Adam K Wheatley;Jennifer A Juno;Jing J Wang;Kevin J Selva

  • Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

    M. Gordon Joyce;Adam K. Wheatley;Paul V. Thomas;Gwo-Yu Chuang

  • Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis.

    Deborah Cromer;Megan Steain;Arnold Reynaldi;Timothy E Schlub;Timothy E Schlub

  • Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

    Masaru Kanekiyo;M Gordon Joyce;M Gordon Joyce;Rebecca A Gillespie;John R Gallagher

  • A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

    Neville K. Kisalu;Azza H. Idris;Connor Weidle;Yevel Flores-Garcia

  • Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine

    Unknown

  • Defining B cell immunodominance to viruses

    Davide Angeletti;James S Gibbs;Matthew Angel;Ivan Kosik

  • Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection

    Deborah Cromer;Jennifer A. Juno;David Khoury;Arnold Reynaldi

  • Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy chain lineages

    James R R Whittle;Adam K. Wheatley;Lan Wu;Daniel Lingwood

  • From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.

    Emily H. Pilkington;Estelle J.A. Suys;Natalie L. Trevaskis;Adam K. Wheatley

  • Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity.

    Marios Koutsakos;Adam K. Wheatley;Liyen Loh;E. Bridie Clemens

  • Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery

    Katelyn T. Gause;Adam K. Wheatley;Jiwei Cui;Yan Yan

  • Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans.

    Henry J. Sutton;Racheal Aye;Racheal Aye;Azza H. Idris;Rachel Vistein

  • Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection.

    Kristin L. Boswell;Robert Paris;Eli Boritz;David Ambrozak

  • Suboptimal SARS-CoV-2-specific CD8 + T cell response associated with the prominent HLA-A*02:01 phenotype.

    Jennifer R. Habel;Thi H.O. Nguyen;Carolien E. van de Sandt;Carolien E. van de Sandt;Jennifer A. Juno

  • Influenza lineage extinction during the COVID-19 pandemic?

    Marios Koutsakos;Adam K. Wheatley;Karen Laurie;Stephen J. Kent;Stephen J. Kent

  • Systems serology detects functionally distinct coronavirus antibody features in children and elderly.

    Kevin J. Selva;Carolien E. van de Sandt;Carolien E. van de Sandt;Melissa M. Lemke;Christina Y. Lee

  • Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.

    Marios Koutsakos;Louise C. Rowntree;Luca Hensen;Brendon Y. Chua;Brendon Y. Chua

  • Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals

    Lela Kardava;Susan Moir;Naisha Shah;Wei Wang

Frequent Co-Authors

Stephen J. Kent
Stephen J. Kent University of Melbourne
Katherine Kedzierska
Katherine Kedzierska University of Melbourne
Adrian B. McDermott
Adrian B. McDermott National Institute of Allergy and Infectious Diseases
Kanta Subbarao
Kanta Subbarao University of Melbourne
Jamie Rossjohn
Jamie Rossjohn Monash University
P. Mark Hogarth
P. Mark Hogarth Burnet Institute
Miles P. Davenport
Miles P. Davenport University of New South Wales
Aeron C. Hurt
Aeron C. Hurt Roche (Switzerland)
Dale I. Godfrey
Dale I. Godfrey University of Melbourne
M. Gordon Joyce
M. Gordon Joyce Henry M. Jackson Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related online degrees can open diverse career opportunities in healthcare and research. Many professionals consider transitioning within the nursing field, such as moving from family nurse practitioner (FNP) roles to acute care settings. Resources on how to fnp to acute care np offer valuable guidance for this career shift.

Accelerated pathways are another strong option, especially for students with previous healthcare experience. Programs listed among the accelerated nurse practitioner program allow candidates to obtain advanced credentials faster, helping them enter the workforce with specialized skills.

Those starting without a nursing background can explore online adn programs for non nurses, which provide foundational knowledge and practical training to begin a nursing career. Such programs often lead to rewarding roles tied to immunology research or patient care.

Understanding financial prospects is crucial when planning education and career moves. Checking the latest dnp salary data by state helps set realistic expectations and tailor goals accordingly.

Best Scientists Citing Adam K. Wheatley

Trending Scientists

Recently Published Articles